CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | Parnell Winfred Director | Option exercise · Restricted Stock Units | −5,157 | 10,312 | ||
| 2024-12-31 | Herchuk Jannie Prestridge Director | Option exercise | +8,437 | 65,627 | ||
| 2024-12-31 | Herchuk Jannie Prestridge Director | Option exercise · Restricted Stock Units | −8,437 | 16,875 | ||
| 2024-12-31 | Fralick Celeste Rachelle Director | Option exercise | +5,000 | 50,665 | ||
| 2024-12-31 | Fralick Celeste Rachelle Director | Option exercise · Restricted Stock Units | −5,000 | 10,000 | ||
| 2024-12-31 | Milligan Sandra Interim CEO & President | Option exercise | +20,000 | 20,000 | ||
| 2024-12-31 | Milligan Sandra Interim CEO & President | Option exercise · Restricted Stock Units | −20,000 | 0 | ||
| 2024-12-31 | Cavanaugh Stefanie L. Director | Option exercise | +5,937 | 66,851 | ||
| 2024-12-31 | Cavanaugh Stefanie L. Director | Option exercise · Restricted Stock Units | −5,937 | 11,875 | ||
| 2024-12-31 | Vos Ellen O'Connor Director | Option exercise | +5,312 | 63,364 | ||
| 2024-12-31 | Vos Ellen O'Connor Director | Option exercise · Restricted Stock Units | −5,312 | 10,625 | ||
| 2024-11-12 | Kallassy John A Interim CFO | Grant or award · Stock Options (Right to buy) | +25,000 | 25,000 | ||
| 2024-11-12 | Milligan Sandra President | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2024-10-28 | Milligan Sandra President | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2024-10-28 | Sandford Nicole Chief Executive Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2024-09-30 | Ragard John Phillip Director | Option exercise | +4,844 | 120,203 | ||
| 2024-09-30 | Ragard John Phillip Director | Option exercise · Restricted Stock Units | −4,844 | 14,531 | ||
| 2024-09-30 | Vos Ellen O'Connor Director | Option exercise | +5,313 | 58,052 | ||
| 2024-09-30 | Vos Ellen O'Connor Director | Option exercise · Restricted Stock Units | −5,313 | 15,937 | ||
| 2024-09-30 | Ragard John Phillip Director | Option exercise | +4,844 | 120,203 |
Page 4 of 15 · 296 trades